Format

Send to

Choose Destination
Int J Mol Sci. 2017 Oct 9;18(10). pii: E2114. doi: 10.3390/ijms18102114.

A Central Bioactive Region of LTBP-2 Stimulates the Expression of TGF-β1 in Fibroblasts via Akt and p38 Signalling Pathways.

Author information

1
Discipline of Anatomy and Pathology, School of Medicine, University of Adelaide, Adelaide, SA 5005, Australia. arshadsideek@iium.edu.my.
2
Department of Physical Rehabilitation Sciences, Kulliyyah of Allied Health Sciences, International Islamic University Malaysia, 25200 Kuantan, Pahang, Malaysia. arshadsideek@iium.edu.my.
3
Discipline of Anatomy and Pathology, School of Medicine, University of Adelaide, Adelaide, SA 5005, Australia. joshua.smith.phd@gmail.com.
4
Discipline of Anatomy and Pathology, School of Medicine, University of Adelaide, Adelaide, SA 5005, Australia. clementine.menz@gmail.com.
5
Discipline of Anatomy and Pathology, School of Medicine, University of Adelaide, Adelaide, SA 5005, Australia. julian.robert.adams@gmail.com.
6
Regenerative Medicine, Future Industries Institute, University of South Australia, Adelaide, SA 5095, Australia. Allison.Cowin@unisa.edu.au.
7
Discipline of Anatomy and Pathology, School of Medicine, University of Adelaide, Adelaide, SA 5005, Australia. mark.gibson@adelaide.edu.au.

Abstract

Latent transforming growth factor-β-1 binding protein-2 (LTBP-2) belongs to the LTBP-fibrillin superfamily of extracellular proteins. Unlike other LTBPs, LTBP-2 does not covalently bind transforming growth factor-β1 (TGF-β1) but appears to be implicated in the regulation of TGF-β1 bioactivity, although the mechanisms are largely unknown. In experiments originally designed to study the displacement of latent TGF-β1 complexes from matrix storage, we found that the addition of exogenous LTBP-2 to cultured human MSU-1.1 fibroblasts caused an increase in TGF-β1 levels in the medium. However, the TGF-β1 increase was due to an upregulation of TGF-β1 expression and secretion rather than a displacement of matrix-stored TGF-β1. The secreted TGF-β1 was mainly in an inactive form, and its concentration peaked around 15 h after addition of LTBP-2. Using a series of recombinant LTBP-2 fragments, the bioactivity was identified to a small region of LTBP-2 consisting of an 8-Cys motif flanked by four epidermal growth factor (EGF)-like repeats. The LTBP-2 stimulation of TGF-β expression involved the phosphorylation of both Akt and p38 mitogen-activated protein kinase (MAPK) signalling proteins, and specific inactivation of each protein individually blocked TGF-β1 increase. The search for the cell surface receptor mediating this LTBP-2 activity proved inconclusive. Inhibitory antibodies to integrins β1 and αVβ5 showed no reduction of LTBP-2 stimulation of TGF-β1. However, TGF-β1 upregulation was partially inhibited by anti-αVβ3 integrin antibodies, suggestive of a direct or indirect role for this integrin. Overall, the study indicates that LTBP-2 can directly upregulate cellular TGF-β1 expression and secretion by interaction with cells via a short central bioactive region. This may be significant in connective tissue disorders involving aberrant TGF-β1 signalling.

KEYWORDS:

Akt; LTBP-2; TGF-β; fibroblast; fibrosis; p38 MAPK

PMID:
28991210
PMCID:
PMC5666796
DOI:
10.3390/ijms18102114
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center